David Tregouet on Molecular Determinants of Thrombosis Recurrence Risk Across VTE Subtypes
David Tregouet, Director of Research in Human Genomics at INSERM U1219, shared an insightful post on LinkedIn:
”There could be no better way to celebrate the 10th anniversary of the first meta-GWAS on VTE (Germain et al. Am J Hum Genet 2015 Apr 2;96(4):532-42.
doi: 10.1016/j.ajhg.2015.01.019. ) than by seeing the first meta-GWAS on recurrence accepted.
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes.
Munsch G, et al. Blood. 2025 Aug 14:blood.2024027879. doi: 10.1182/blood.2024027879. Online ahead of print. PMID: 40811855”
Read the full article here.
Article: Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes
Authors: Gaëlle Munsch, Florian Thibord, Ohanna C Bezerra, Jennifer A Brody, Astrid van Hylckama Vlieg, Lenaick Gourhant, Ming-Huei Chen, Floriane Samaria, Marine Germain, Ilana Caro, Pierre Suchon, Robert Olaso, Kerri L Wiggins, Noémie Saut, Céline Besse, Louisa Goumidi, Delphine Bacq, Laura B Harrington, Anne Boland, Joseph Emmerich David M Smadja, Catherine A Lemarie, Sven Danckwardt, Stephanie Debette, Jean-François Deleuze, Hélène Jacqmin-Gadda, Marc A Rodger, France Gagnon, Frits R Rosendaal, Andrew D Johnson, Nicholas L Smith, Francis Couturaud, Pierre-Emmanuel Morange, David-Alexandre Tregouet
Stay informed on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 18, 2025, 23:54TNF-α–Mediated Platelet Dysfunction: Inflammation, Autophagy Inhibition, and Thrombosis Risk
-
Aug 18, 2025, 23:53Radiotherapy and VTE Risk: Insights from Marc Carrier and Colleagues
-
Aug 18, 2025, 23:52PCI and Bleeding Risk: Shea E. Hogan Reviews Aspirin-Free Approaches
-
Aug 18, 2025, 23:49Ahmed Kotb: HHT Management—Choosing the Right Therapy?
-
Aug 18, 2025, 23:48Pulmonary Embolism Management: Experts Share Valuable Insights on Endovascular Today
-
Aug 19, 2025, 18:18Hélène Gleitz-Broeders: Targeting Stromal Crosstalk to Reverse Bone Marrow Fibrosis
-
Aug 19, 2025, 17:58David Tregouet on Molecular Determinants of Thrombosis Recurrence Risk Across VTE Subtypes
-
Aug 19, 2025, 17:36Omid Seidizadeh: Effect of Some Polymorphic Variants on the Platelet-Dependent VWF Activity Assays
-
Aug 18, 2025, 23:54Davide Capodanno Shares FITTER Trial: Evolocumab Shows No Added Short-Term Benefit in Acute Coronary Syndrome
-
Aug 18, 2025, 11:04Albert Farrugia: The Past, Present and Future of Blood Plasma Fractionation
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 15, 2025, 03:44Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth